SCHEMBL15566769

SCHEMBL15566769

c1cc2ccc([C]3CC3)cc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.52
CMA1 P23946 1/20 0.52
TYR P14679 1/20 0.52
CYP2A6 P11509 1/20 0.52
BRD4 O60885 1/20 0.47
ENPP2 Q13822 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
GPR84 Q9NQS5 1/20 0.43
APP P05067 1/20 0.43
TRPA1 O75762 1/20 0.43
CA1 P00915 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL443799 0.77 NPC1 (0.71) AHRCMA1TYRCYP2A6BRD4
SCHEMBL30253604 0.77 NPC1 (0.71) AHRCMA1TYRCYP2A6BRD4
SCHEMBL2530865 0.75 GPR84 (0.67) AHRCMA1TYRCYP2A6ENPP2
SCHEMBL7085378 0.75 AHR (0.70) AHRCMA1TYRCYP2A6BRD4
SCHEMBL28284305 0.75 AHR (0.70) AHRCMA1TYRCYP2A6BRD4
SCHEMBL1225643 0.75 TYR (0.70) AHRCMA1TYRBRD4ENPP2
SCHEMBL13115618 0.75 BRD4 (0.53) AHRCMA1TYRCYP2A6BRD4
SCHEMBL7084471 0.75 NPC1 (0.58) AHRCMA1TYRCYP2A6BRD4
SCHEMBL147946 0.75 AHR (0.70) AHRCMA1TYRCYP2A6BRD4
SCHEMBL20370288 0.74 LCK (0.49) AHRCMA1TYRCYP2A6BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
EP-2882722-A1 QUINOXALINE DERIVATIVES AS GPR6 MODULATORS Envoy Therapeutics Inc. (US) 2015-06-17 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed
WO-2014028479-A1 QUINOXALINE DERIVATIVES AS GPR6 MODULATORS ENVOY THERAPEUTICS, INC. (US) 2014-02-20 WO disclosed